Evidence map›Paper›PMID 26902899›Full record

ArticleJournal of immunological methods2016

High-throughput allogeneic antibody detection using protein microarrays.

Jed Paul, Bita Sahaf, Spenser Perloff, Kelsi Schoenrock, Fang Wu, Hideki Nakasone, John Coller, David Miklos

Abstract readComparative Study
In one paragraph

Article in Journal of immunological methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jed PaulDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, 269 West Campus Dr., CCSR #2205, Stanford, CA 94305, United States. Electronic address: jedpaul@stanford.edu.
Bita SahafDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, 269 West Campus Dr., CCSR #2205, Stanford, CA 94305, United States. Electronic address: bsahaf@stanford.edu.
Spenser PerloffDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, 269 West Campus Dr., CCSR #2205, Stanford, CA 94305, United States. Electronic address: shperloff@ucdavis.edu.
Kelsi SchoenrockDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, 269 West Campus Dr., CCSR #2205, Stanford, CA 94305, United States.
Fang WuDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, 269 West Campus Dr., CCSR #2205, Stanford, CA 94305, United States. Electronic address: fangw@stanford.edu.
Hideki NakasoneDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, 269 West Campus Dr., CCSR #2205, Stanford, CA 94305, United States. Electronic address: nakasone-tky@umin.ac.jp.
John CollerStanford Functional Genomics Facility, Stanford University School of Medicine, 269 West Campus Dr., CCSR #0120, Stanford, CA 94305, United States. Electronic address: john.coller@stanford.edu.
David MiklosDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, 269 West Campus Dr., CCSR #2205, Stanford, CA 94305, United States. Electronic address: dmiklos@stanford.edu.
Stanford Blood Center · USStanford Medicine · USStanford University · US

Funding

TUMOR SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN BONE MARROW TRANSPLANTATIONP01CA049605 · NCI · STANFORD UNIVERSITY · PI David B. Miklos · 1989 to 2026
$73.3M
Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
Microarray Analysis of H-Y Antibodies in Human TransplantationR21HL084318 · NHLBI · STANFORD UNIVERSITY · PI MIKLOS, DAVID B. · 2007 to 2008
$434k
NCI NIH HHS P01 CA049605NCI NIH HHS P30 CA124435NHLBI NIH HHS R21 HL084318
6 · The paper itself

Abstract

Enzyme-linked immunosorbent assays (ELISAs) have traditionally been used to detect alloantibodies in patient plasma samples post hematopoietic cell transplantation (HCT); however, protein microarrays have the potential to be multiplexed, more sensitive, and higher throughput than ELISAs. Here, we describe the development of a novel and sensitive microarray method for detection of allogeneic antibodies against minor histocompatibility antigens encoded on the Y chromosome, called HY antigens. Six microarray surfaces were tested for their ability to bind recombinant protein and peptide HY antigens. Significant allogeneic immune responses were determined in male patients with female donors by considering normal male donor responses as baseline. HY microarray results were also compared with our previous ELISA results. Our overall goal was to maximize antibody detection for both recombinant protein and peptide epitopes. For detection of HY antigens, the Epoxy (Schott) protein microarray surface was both most sensitive and reliable and has become the standard surface in our microarray platform.

Indexed as

High-Throughput Screening AssaysHistocompatibilityAdolescentAdultAgedBiomarkersChildChronic DiseaseEnzyme-Linked Immunosorbent AssayEpitopesFemaleGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHistocompatibility TestingHumansH-Y AntigenBiomarkersEpitopesH-Y AntigenIsoantibodiesAlloantibodyChronic graft versus host diseaseHematopoietic cell transplantationHY antigenProtein microarray

Identifiers

PMID26902899
PMCPMC5495102
OpenAlexW2281623855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.